Marjorie A. Speers, Ph.D., is executive director of Clinical Research Pathways. She is available to discuss how clinical trials should include more minority patients. In a recent article on Forbes.com, Morris Panner, CEO of Ambra Health, talks about how diversity in drug trials is severely lacking:

https://www.forbes.com/sites/forbestechcouncil/2019/10/15/diversity-is-severely-lacking-among-clinical-trial-participants-how-can-we-solve-this-problem/#4949cbdf11a7

MEDIA CONTACT
Register for reporter access to contact details
TYPE OF ARTICLE
Expert Pitch
SECTION
CHANNELS
Clinical Trials Healthcare Ethics and Research Methods Race and Ethnicity Pharmaceuticals
KEYWORDS
Clinical Trial Diversity and Inclusion clinical trial design Clinical Trials Medical Research Drug Development Pharmaceucticals Drug Research and Development Minority Patients
COMMENTS | COMMENTING POLICY
View All Latest News